Battling HIV/AIDS [[electronic resource] ] : a decision maker's guide to the procurement of medicines and related supplies / / Yolanda Taylor |
Autore | Tayler Yolanda <1957-> |
Pubbl/distr/stampa | Washington, DC, : World Bank, 2004 |
Descrizione fisica | xxv, 152 p |
Disciplina | 362.196/9792061 |
Soggetto topico |
Antiretroviral agents - Purchasing
AIDS (Disease) - Chemotherapy - Economic aspects HIV infections - Chemotherapy - Economic aspects Pharmaceutical industry - Developing countries Pharmaceutical policy - Developing countries |
Soggetto genere / forma | Electronic books. |
ISBN |
1-280-08422-7
9786610084227 1-4175-2616-5 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910455954303321 |
Tayler Yolanda <1957-> | ||
Washington, DC, : World Bank, 2004 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Battling HIV/AIDS : : a decision maker's guide to the procurement of medicines and related supplies / / Yolanda Tayler, editor |
Autore | Tayler Yolanda <1957-> |
Pubbl/distr/stampa | Washington, DC : , : World Bank, , [2004] |
Descrizione fisica | xxv, 152 pages : illustrations ; ; 23 cm |
Disciplina | 362.196/9792061 |
Altri autori (Persone) | TaylerYolanda <1957-> |
Soggetto topico |
Antiretroviral agents - Purchasing
AIDS (Disease) - Chemotherapy - Economic aspects HIV infections - Chemotherapy - Economic aspects Pharmaceutical industry - Developing countries Pharmaceutical policy - Developing countries |
ISBN |
1-280-08422-7
9786610084227 1-4175-2616-5 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910780591803321 |
Tayler Yolanda <1957-> | ||
Washington, DC : , : World Bank, , [2004] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Battling HIV/AIDS : a decision maker's guide to the procurement of medicines and related supplies / / Yolanda Taylor |
Autore | Tayler Yolanda <1957-> |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Washington, DC, : World Bank, 2004 |
Descrizione fisica | xxv, 152 pages : illustrations ; ; 23 cm |
Disciplina | 362.196/9792061 |
Soggetto topico |
Antiretroviral agents - Purchasing
AIDS (Disease) - Chemotherapy - Economic aspects HIV infections - Chemotherapy - Economic aspects Pharmaceutical industry - Developing countries Pharmaceutical policy - Developing countries |
ISBN |
1-280-08422-7
9786610084227 1-4175-2616-5 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Intro -- Contents -- Foreword -- Executive Summary -- Preface -- Acknowledgments -- Abbreviations -- 1 Challenges in Scaling up Treatment -- The economic impact of HIV/AIDS and ART -- Estimating resource requirements -- Long-term economic effect of HIV/AIDS and other considerations -- 2 Intellectual Property Rights: A Concise Guide -- Introduction to this concise guide -- How patents affect medicines procurement -- Least developed countries -- Developing countries -- A note on "parallel imports" -- Registration and data exclusivity -- 3 Managing the Supply Cycle for Better Outcomes -- Who does what? -- What tasks need to be done? -- Who is already carrying out these tasks? -- Monitoring procurement results -- 4 Product Selection, Quantification, and Quality Assurance -- Product selection -- How drugs should be selected for HIV-related treatment -- Product quantification -- Quality assurance and supplier selection -- Testing and laboratory capacity -- 5 Procurement -- Assessing capacity -- Commodities that support the HIV/AIDS program -- Planning procurement -- Registering products -- Choosing procurement methods -- 6 Pricing -- What determines drug prices? -- Additional price determinants in retail markets -- How can public purchasers bargain for low prices? -- Annex A. Estimating Resource Requirements for AIDS Treatment -- Annex B. Intellectual Property Rights: How They Affect Procurement and What Steps Can Be Taken -- Annex C. HIV Test Kits and Other Diagnostics -- Glossary -- Index -- Boxes -- 1.1 The long-term economic consequences of AIDS in South Africa -- 1.2 ART and drug resistance -- 3.1 Who can help in selection and quantification? -- 3.2 Who can help with regulatory issues of product registration, intellectual property, and import? -- 3.3 Who can help with procurement? -- 3.4 Who can help with storage and distribution?.
4.1 Useful references for quantification -- 5.1 Social marketing: another way to distribute -- 5.2 Useful references on procurement -- 6.1 Examples of pooled procurement initiatives -- 6.2 Sources of information on production costs and prices -- 6.3 Evidence of equity pricing for ARVs -- B.1 Parallel importing -- B.2 Parallel imports in South Africa-under the rule of international exhaustion -- Figures -- 2.1 Intellectual property rights checklist: least developed country -- 2.2 Intellectual property rights checklist: developing country -- 2.3 Can a country use World Bank funds to procure generic ARVs? -- 3.1 The medicines supply cycle -- 3.2 Tasks and stages of the supply cycle -- 5.1 Commodities that support the HIV/AIDS program -- 5.2 Procurement flowchart -- 6.1 Pharmaceutical supply chain -- 6.2 Drug procurement and options for lowering prices -- Tables -- 4.1 WHO recommendations for initiating ART in adults and adolescents with documented HIV infection -- 4.2 WHO first-line ARV regimens in adults and adolescents and characteristics that can influence choice -- 4.3 Quantification methods -- 4.4 Calculating procurement quantities -- 4.5 Multisource and single- and limited-source products -- A.1 People living with HIV/AIDS in Burkina Faso, 2003-10 -- A.2 Projected cost of ART (drugs only) for all people with AIDS under high cost (1,000), low cost (333), and lowest cost ( -- A.3 Projected total cost of ART, per person per year, 2003 -- A.4 Projected total cost of ART for all people with AIDS in Burkina Faso, under high cost (1,730) and lowest cost (620) price scenarios, 2003-10 -- A.5 Projected number of people living with HIV/AIDS in Kenya and South Africa, 2002-10 -- A.6 Projected cost of ART (drugs only) for all people with AIDS in Kenya, under high cost (1,000), low cost (333), and lowest cost (140) price scenarios, 2002-10. A.7 Projected cost of ART (drugs only) for all people with AIDS in South Africa, under high cost (1,000), low cost (333), and lowest cost (140) price scenarios, 2002-10 . -- A.8 Projected total costs of ART, per person per year, in Kenya and South Africa. |
Record Nr. | UNINA-9910807336503321 |
Tayler Yolanda <1957-> | ||
Washington, DC, : World Bank, 2004 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Equity in access to AIDS treatment in Africa : Chicoutimi / / Alice Desclaux |
Autore | Desclaux Alice |
Pubbl/distr/stampa | Chicoutimi : , : J.-M. Tremblay, , 2009 |
Descrizione fisica | 1 online resource |
Disciplina | 362.1091724 |
Collana | Classiques des sciences sociales |
Soggetto topico |
Medical policy - Developing countries
Pharmaceutical industry - Developing countries |
ISBN | 1-4123-7078-7 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | fre |
Nota di contenuto | The International Issue of Access to HAART in Africa -- From International to Local Access to Treatment -- The ISAARV Program -- The Establishment of a Pilot Project -- Achievements of the Program -- Social Impact of Equity Management in ISAARV -- Noninclusions -- Adherence Problems -- Compensations for Family Support -- Analyses of a System -- Limitations of a System Aiming at Equity -- After the November 2000 Price Reductions -- Low Prices and Free Treatment as the Final Choice -- Discussion -- Selection Based on Social Criteria -- Low Prices or Free Treatment for All Patients -- Implications -- Paying for Treatment: Meaningful for Whom? -- Double Payment for HIV Patients? -- Social Impact of "Community-Based" Management of Equity? -- Conclusion -- References. |
Altri titoli varianti | Equity in access to AIDS treatment in Africa |
Record Nr. | UNINA-9910132733903321 |
Desclaux Alice | ||
Chicoutimi : , : J.-M. Tremblay, , 2009 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Journal of pharmaceutical policy and practice |
Pubbl/distr/stampa | London : , : BioMed Central, , 2013- |
Descrizione fisica | 1 online resource |
Soggetto topico |
Pharmacy - Research
Pharmacy - Research - Developing countries Pharmaceutical industry Pharmaceutical industry - Developing countries Pharmaceutical policy Pharmaceutical policy - Developing countries Technology, Pharmaceutical |
Soggetto genere / forma |
Periodical
Periodicals. Fulltext Internet Resources. |
ISSN | 2052-3211 |
Formato | Materiale a stampa |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Altri titoli varianti | JoPPP |
Record Nr. | UNISA-996210782103316 |
London : , : BioMed Central, , 2013- | ||
Materiale a stampa | ||
Lo trovi qui: Univ. di Salerno | ||
|
Journal of pharmaceutical policy and practice |
Pubbl/distr/stampa | London : , : BioMed Central, , 2013- |
Descrizione fisica | 1 online resource |
Soggetto topico |
Pharmacy - Research
Pharmacy - Research - Developing countries Pharmaceutical industry Pharmaceutical industry - Developing countries Pharmaceutical policy Pharmaceutical policy - Developing countries Technology, Pharmaceutical |
Soggetto genere / forma |
Periodical
Periodicals. Fulltext Internet Resources. |
ISSN | 2052-3211 |
Formato | Materiale a stampa |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Altri titoli varianti | JoPPP |
Record Nr. | UNINA-9910141849303321 |
London : , : BioMed Central, , 2013- | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Social and administrative aspects of pharmacy in low- and middle-income countries : present challenges and future solutions / / edited by Mohamed Izham Mohamed Ibrahim, Albert I. Wertheimer, Zaheer-Ud-Din Babar |
Pubbl/distr/stampa | London, England : , : Academic Press, , 2018 |
Descrizione fisica | 1 online resource (457 pages) : illustrations |
Disciplina | 338.476151091724 |
Soggetto topico |
Pharmaceutical industry - Developing countries
Pharmacy - Developing countries |
ISBN | 0-12-811229-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910583325303321 |
London, England : , : Academic Press, , 2018 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Understanding drugs markets : an analysis of medicines, regulations, and pharmaceutical systems in the global south / / edited by Carine Baxerres and Maurice Cassier |
Pubbl/distr/stampa | London, England ; ; New York, New York : , : Routledge, , [2022] |
Descrizione fisica | 1 online resource (321 pages) |
Disciplina | 338.476151091724 |
Soggetto topico |
Health services administration - Developing countries
Medical policy - Developing countries Pharmaceutical industry - Developing countries |
ISBN |
0-429-32951-2
1-000-41314-4 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Cover -- Half Title -- Series Page -- Title Page -- Copyright Page -- Dedication -- Contents -- List of figures -- List of tables -- List of contributors -- Foreword -- Acknowledgments -- List of abbreviations -- Introduction: Pharmaceutical markets in the Global South: Shaped by history and multiple regulations -- PART I: Varying choices for State regulation and their consequences -- 1. Strengthening national pharmaceutical regulation through local production -- 2. Strengths and weaknesses of State-controlled wholesale distribution: Benin's CAME and wholesaler-distributors -- 3. Distribution and access to medicines: Role of the pharmacist monopoly -- 4. From depharmaceuticalization to drug abundance: A social history of pharmaceutic regulations in Cambodia -- PART II: Global and local markets of new antimalarials -- 5. A new geography of pharmaceuticals: Trajectories of artemisinin-based medicines -- 6. Clashes between subsidized and private ACT markets: When administrative, Global Health, and marketing regulations collide -- 7. When the pharmaceutical system creates persistent attachments or new appropriations of drug molecules: Divergent ACT distribution and use in Benin and Ghana -- 8. Standardized herbal medicines in Ghana: The construction of a substantial share of the medicine market, especially for malaria -- PART III: Pharmaceuticalization: Medicines at the heart of health systems and societies -- 9. Pharmaceutical representative activities in Benin and Ghana: Promoting firms while helping construct the pharmaceutical economy of African countries -- 10. Self-medication versus consultation: Individual autonomy and dependence in health decisions -- 11. When subjective quality shapes the whole economy of pharmaceutical distribution and production -- Conclusion: Rationalizing drug markets in the Global South -- Index. |
Record Nr. | UNINA-9910518191903321 |
London, England ; ; New York, New York : , : Routledge, , [2022] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|